FHI vs HLNE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

FHI

57.5
AI Score
VS
FHI Wins

HLNE

47.4
AI Score

Investment Advisor Scores

FHI

58score
Recommendation
HOLD

HLNE

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric FHI HLNE Winner
Forward P/E 11.534 13.5685 FHI
PEG Ratio 2.3532 1.39 HLNE
Revenue Growth 18.3% -2.2% FHI
Earnings Growth 19.3% 4.1% FHI
Tradestie Score 57.5/100 47.4/100 FHI
Profit Margin 21.3% 32.8% HLNE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

FHI 1M: +10.5% · 3M: +18.5% HLNE 1M: +20.3% · 3M: +8.8%

Current Technical Phase

FHI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.8% over 20 days), RSI 70

RSI (14): 69.7 · Price: $63.98

HLNE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 75

RSI (14): 75.5 · Price: $99.18

Fundamentals Snapshot

Metric FHI HLNE
Market Cap
Forward P/E 10.9 15.8
Trailing P/E 11.1 15.0
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.7% 0.6%
Operating Margin 0.3% 0.4%
EPS 5.38 5.92
Dividend Yield 0.02% 0.02%

Frequently Asked Questions

Based on our detailed analysis, FHI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.